Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Methylphenidate | The risk or severity of adverse effects can be increased when Methylphenidate is combined with 3,5-Dinitrocatechol. |
| Dexmethylphenidate | The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with 3,5-Dinitrocatechol. |
| Metoclopramide | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Metoclopramide. |
| Ziprasidone | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Ziprasidone. |
| Olanzapine | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Olanzapine. |
| Clozapine | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Clozapine. |
| Risperidone | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Risperidone. |
| Quetiapine | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Quetiapine. |
| Aripiprazole | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Aripiprazole. |
| Paliperidone | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Paliperidone. |
| Bifeprunox | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Bifeprunox. |
| Iloperidone | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Iloperidone. |
| Cariprazine | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Cariprazine. |
| Lumateperone | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Lumateperone. |
| Sertindole | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Sertindole. |
| Asenapine | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Asenapine. |
| Lurasidone | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Lurasidone. |
| Perospirone | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Perospirone. |
| Brexpiprazole | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Brexpiprazole. |
| Blonanserin | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Blonanserin. |
| Melperone | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Melperone. |
| Zotepine | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Zotepine. |
| Brilaroxazine | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Brilaroxazine. |
| Amisulpride | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Amisulpride. |
| Pipamperone | The therapeutic efficacy of Pipamperone can be decreased when used in combination with 3,5-Dinitrocatechol. |
| Loxapine | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Loxapine. |
| Promazine | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Promazine. |
| Prochlorperazine | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Prochlorperazine. |
| Droperidol | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Droperidol. |
| Chlorpromazine | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Chlorpromazine. |
| Haloperidol | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Haloperidol. |
| Fluphenazine | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Fluphenazine. |
| Thioridazine | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Thioridazine. |
| Trifluoperazine | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Trifluoperazine. |
| Perphenazine | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Perphenazine. |
| Mesoridazine | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Mesoridazine. |
| Pimozide | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Pimozide. |
| Chlorprothixene | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Chlorprothixene. |
| Methotrimeprazine | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Methotrimeprazine. |
| Periciazine | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Periciazine. |
| Molindone | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Molindone. |
| Thioproperazine | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Thioproperazine. |
| Thiothixene | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Thiothixene. |
| Zuclopenthixol | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Zuclopenthixol. |
| Azaperone | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Azaperone. |
| Diethylstilbestrol | The metabolism of Diethylstilbestrol can be decreased when combined with 3,5-Dinitrocatechol. |
| Conjugated estrogens | The metabolism of Conjugated estrogens can be decreased when combined with 3,5-Dinitrocatechol. |
| Norepinephrine | The metabolism of Norepinephrine can be decreased when combined with 3,5-Dinitrocatechol. |
| Epinephrine | The metabolism of Epinephrine can be decreased when combined with 3,5-Dinitrocatechol. |
| Dobutamine | The metabolism of Dobutamine can be decreased when combined with 3,5-Dinitrocatechol. |
| Methyldopa | The metabolism of Methyldopa can be decreased when combined with 3,5-Dinitrocatechol. |
| Dopamine | The metabolism of Dopamine can be decreased when combined with 3,5-Dinitrocatechol. |
| Micafungin | The metabolism of Micafungin can be decreased when combined with 3,5-Dinitrocatechol. |
| Quercetin | The metabolism of Quercetin can be decreased when combined with 3,5-Dinitrocatechol. |
| Echinacoside | The metabolism of Echinacoside can be decreased when combined with 3,5-Dinitrocatechol. |
| Phenytoin | The metabolism of Phenytoin can be decreased when combined with 3,5-Dinitrocatechol. |
| Ethinylestradiol | The metabolism of Ethinylestradiol can be decreased when combined with 3,5-Dinitrocatechol. |
| Apomorphine | The metabolism of Apomorphine can be decreased when combined with 3,5-Dinitrocatechol. |
| Estradiol | The metabolism of Estradiol can be decreased when combined with 3,5-Dinitrocatechol. |
| Isoprenaline | The metabolism of Isoprenaline can be decreased when combined with 3,5-Dinitrocatechol. |
| Tranylcypromine | The risk or severity of adverse effects can be increased when 3,5-Dinitrocatechol is combined with Tranylcypromine. |
| Phenelzine | The risk or severity of adverse effects can be increased when 3,5-Dinitrocatechol is combined with Phenelzine. |
| Isocarboxazid | The risk or severity of adverse effects can be increased when 3,5-Dinitrocatechol is combined with Isocarboxazid. |
| Iproniazid | The risk or severity of adverse effects can be increased when 3,5-Dinitrocatechol is combined with Iproniazid. |
| Nialamide | The risk or severity of adverse effects can be increased when 3,5-Dinitrocatechol is combined with Nialamide. |
| Safrazine | The risk or severity of adverse effects can be increased when 3,5-Dinitrocatechol is combined with Safrazine. |
| Bupropion | The risk or severity of adverse effects can be increased when Bupropion is combined with 3,5-Dinitrocatechol. |
| Flupentixol | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Flupentixol. |
| Aripiprazole lauroxil | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Aripiprazole lauroxil. |